Although NRF2 is known to promote tumor progression in pancreatic cancer (14, 15), it has also been implicated in tumor suppression in certain gastrointestinal malignancies, including chemically induced gastric (35) and colon (36) cancers. Here, NFE2L2 is linked to cancer.